Register
Login:
Share:
Email Facebook Twitter

LSE Natural Resources Webcast - Ariana Resources, Strategic Minerals, Amur Minerals, Amanda van Dyke Watch Here

EXCLUSIVE: Robin Young, CEO, Amur Minerals #AMC talks long-term strategy


Immupharma Share Price (IMM)



Share Price Information for Immupharma (IMM)


Share Price: 29.10Bid: 28.20Ask: 29.50Change: 0.10 (+0.34%)Riser - Immupharma
Spread: 1.30Spread as %: 4.61%Open: 28.00High: 29.90Low: 28.00Yesterday’s Close: 29.00

Immupharma Plc Ord 10P

Immupharma is listed in the FTSE AIM All-Share
Immupharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
29.10
Share Price SpacerBid
28.20
Share Price SpacerAsk
29.50
Share Price SpacerChange
0.34%0.10
Share Price SpacerVolume
718,289
Share Price SpacerOpen
28.00
Share Price SpacerHigh
29.90
Share Price SpacerLow
28.00
Share Price SpacerClose
29.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 139.47m £40.59m 3,000

52 Week High 193.00 52 Week High Date 4-JAN-2018
52 Week Low 19.00 52 Week Low Date 17-APR-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
121 371,895 344,586 -6.410 -4.54 0.00 0.00


London South East Users info for Immupharma




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-May-18
16:52:29
28.43
23,676
Sell* 
28.20
29.50
6,731
Trade Type:
Ordinary

21-May-18
16:51:32
28.8844
11,200
Buy* 
28.20
29.50
3,235
Trade Type:
Ordinary

21-May-18
16:51:22
29.0931
10,300
Buy* 
28.20
29.50
2,997
Trade Type:
Ordinary




View more Immupharma trades >>

Directors Deals for Immupharma (IMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Apr-15Notification of Holding
Trade Notifier Information for Immupharma
Stephane Robert George Mery held the position of Non-Executive Director at Immupharma at the time of this trade.
 Stephane Robert George Mery
002259
24-Jan-13Sell
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
57GBX62,1690
24-Jan-12Buy
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
80GBX62,1690
View more Immupharma directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 17:01EleganceBlue day29.10No Opinion
Strongman I agree, looking forward to hearing some good news this week from Immupharma.
Today 16:13StrongmanRE: Nolupus29.80No Opinion
Good afternoon halfbutt, I trust you are well.
Today 16:12halfbuttRE: Nolupus29.80No Opinion
Looking good end to the day ...
Today 15:25StrongmanNolupus28.80No Opinion
Never know if he is coming or going LOL. Certainly having a bad day today.

Lets hope for some news from board this week, its been long enough now, so fingers crossed for a 7am RNS one day this week.
Today 10:51EleganceThe week ahead28.80No Opinion
Personally hoping for some good news this week ;)
Today 09:54a-2-bRE: IMM28.80No Opinion
Even cornering the European part (20%) is nothing to be snuffed at considering the mcap is so low lol

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Immupharma (IMM) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.